Score is derived from signal source quality, congressional committee alignment, position size, timing relative to legislation, and convergence with other smart money sources.
**LHX | CONGRESSIONAL BUY SIGNAL** Dr. Richard Dean McCormick filed a STOCK Act disclosure on June 12, 2026, buying $500 of LHX. This is a small position, but it's the actor that matters here. McCormick's disclosed trades have a documented edge—they've historically beaten the market. That track record gives this signal real credibility, especially on a defense contractor like LHX where committee access and forward visibility matter. A $500 buy from someone with a proven edge isn't casual portfolio rebalancing; it's directional conviction. The 71/100 conviction score reflects that reliability without overstating a small dollar amount. Watch for LHX to hold above recent support levels while you track upcoming defense spending votes or earnings catalysts within the next 60 days. If McCormick adds to the position or related insiders follow, that's your confirmation. The risk is that small position sizes can move on noise—don't chase on this signal alone, but use it as a green light to build a thesis on LHX fundamentals. His track record says he sees something; your job is to validate it.
The STOCK Act (2012) requires all members of Congress to report stock transactions within 45 days. This disclosure was filed by Richard Dean Dr Mccormick and processed by Flow Antenna's congressional trade monitor. All data is sourced from public SEC/House/Senate disclosure filings.
See every congressional trade Richard Dean Dr Mccormick has filed, their win rate, and what $10,000 invested following their signals would be worth today.
View Richard Dean Dr Mccormick backtest →Flow Antenna notifies you instantly - before it appears in the news cycle.